Dr. Naeem Bhojani, MD
Claim this profileCentre Hospitalier de l'université de Montréal (CHUM)
Studies Benign Prostatic Hyperplasia
Studies Enlarged Prostate
6 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Naeem Bhojani, MD is currently running
LithoVue Elite Ureteroscope
for Kidney Stones
Flexible ureteroscopy has become the main surgical treatment for kidney stone disease. The procedure uses many types of ureteroscopes (disposable and non-disposable). Currently we are using the LithoVue Single-Use Digital Flexible Ureteroscope. The Health Canada approved LithoVue Elite disposable flexible ureteroscope will now offer novel pressure sensory capacity. In order to evaluate the new ureteroscopy we will be conducting a prospective multi-institution study in order to determine the main features, capacity and abilities of the new scope. We will evaluate the impact of intra renal pressure on pain, quality of life and possible infectious complications.
Recruiting1 award N/A3 criteria
Aquablation Therapy
for Enlarged Prostate
Lower urinary symptoms (LUTS) affect many older men and their frequency and severity increase with age. In the age group between 65 and 79 years the rate of men with moderate and severe LUTS is 20 - 25% (Hunter et al. 1994). The complaints are potentially associated with a considerable impairment of the quality of life (Trueman et al. 1999). LUTS in older men are commonly caused by a bladder outlet obstruction (BOO) secondary to benign prostatic enlargement (BPE). The histological term "benign prostatic hyperplasia" (BPH) is frequently used in literature and clinical practice as a synonym for this diagnosis. Surgical therapy of BPH has continuously evolved in recent years. One of the latest technologies for transurethral prostate desobstruction is the Aquablation therapy, first described in 2015 (AQUABEAM®, PROCEPT BioRobotics, Redwood Shores, CA, USA) (Faber et al 2015). The AQUABEAM Robotic System is the first and only image-guided, heat-free robotic therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). It is designed for cutting of prostate tissue during a minimally invasive surgical procedure. Once inserted via a transurethral approach and advanced through the urethra and into the prostatic urethra, the device applies an ultrasound-guided water jet that precisely ablates the prostate tissue. Aquablation therapy is unique in that it combines cystoscopic visualization, ultrasound imaging and advanced planning software to provide the surgeon with a multidimensional view of the treatment area. This enables personalized treatment planning for the patient's unique anatomy, improved decisionmaking and real-time monitoring during the procedure. This prospective single-arm investigational clinical trial aims at assessing the efficacy and safety of the new generation of the AQUABEAM Robotic System (P1G3) and the Apogee 2300 Ultrasound System and compare the percentage of patients who are discharged the day of the surgery among different groups of BPH patients who undergo aquablation using the third generation of the AQUABEAM Robotic System.
Recruiting1 award N/A3 criteria
More about Naeem Bhojani, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Naeem Bhojani, MD has experience with
- LithoVue 2.0
- LithoVue Elite
- Thulium Fiber Laser
- Apogee 2300 Digital Color Doppler Ultrasound Imaging System
- AQUABEAM Robotic System
- Optilume BPH Catheter System
Breakdown of trials Naeem Bhojani, MD has run
Benign Prostatic Hyperplasia
Enlarged Prostate
Mammary Gland Hyperplasia
Evaluating Lower Urinary Tract Symptoms and Quality of Life in Night Workers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Naeem Bhojani, MD specialize in?
Naeem Bhojani, MD focuses on Benign Prostatic Hyperplasia and Enlarged Prostate. In particular, much of their work with Benign Prostatic Hyperplasia has involved treating patients, or patients who are undergoing treatment.
Is Naeem Bhojani, MD currently recruiting for clinical trials?
Yes, Naeem Bhojani, MD is currently recruiting for 4 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Naeem Bhojani, MD has studied deeply?
Yes, Naeem Bhojani, MD has studied treatments such as LithoVue 2.0, LithoVue Elite, Thulium Fiber Laser.
What is the best way to schedule an appointment with Naeem Bhojani, MD?
Apply for one of the trials that Naeem Bhojani, MD is conducting.
What is the office address of Naeem Bhojani, MD?
The office of Naeem Bhojani, MD is located at: Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec QC H2X 0A9 Canada. This is the address for their practice at the Centre Hospitalier de l'université de Montréal (CHUM).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.